CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BIOCAPAN aims to improve diabetes treatment by developing a microcapsule for allogeneic islet cell transplantation. This innovative approach seeks to enhance the longevity and functionality of islet cells, potentially allowing for insulin-free management of diabetes without the need for immunosuppressants.
The key therapeutic issue in diabetes mellitus type I and II is glycaemic control.
Reductions of constant self-control, of insulin injections, and of long-term complications would have tremendous benefit for quality of life.
The best therapy option is the transplantation of allogeneic islet cells, but the current state of the art limits the applicability of this approach.
Implanting unprotected grafts requires lifelong administration of immunosuppressants, and protecting the cells against advers…
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Louvain La Neuve
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Germany, Berlin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Norway, SANDVIKA
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
